Cargando…
ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
A disintegrin and metalloproteinase (ADAM) family proteins, acting as sheddases, are important factors in a number of pathologies, including cancer, and have been suggested as promising therapeutic targets. The study presented focuses on the involvement of ADAM10 and ADAM17 in retinoblastoma (RB), t...
Autores principales: | Van Meenen, Dario, Doege, Annika, Alefeld, Emily, Haase, André, Beier, Manfred, Kiefer, Tobias, Biewald, Eva, Metz, Klaus, Dräger, Oliver, Busch, Maike Anna, Dünker, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604041/ https://www.ncbi.nlm.nih.gov/pubmed/36293469 http://dx.doi.org/10.3390/ijms232012621 |
Ejemplares similares
-
TFF1 in Aqueous Humor—A Potential New Biomarker for Retinoblastoma
por: Busch, Maike Anna, et al.
Publicado: (2022) -
Trefoil Family Factor Peptide 1—A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy
por: Busch, Maike Anna, et al.
Publicado: (2023) -
Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma
por: Miroschnikov, Natalia, et al.
Publicado: (2023) -
ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014) -
Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets
por: Dräger, Oliver, et al.
Publicado: (2021)